Fendosal (HP 129): a potent anti-inflammatory and analgesic compound.
Fendosal (HP 129) is one of a series of potent non-steroidal anti-inflammatory agents. Fendosal was compared with aspirin in several anti-inflammatory and analgesic bioassay procedures. Results indicate that fendosal has an anti-inflammatory activity 1.4 times greater than does aspirin in carrageenan-induced rat paw edema. Fendosal is 6.9 to 9.5 times more active than aspirin in the prophylactic and therapeutic adjuvant-induced polyarthritis models of chronic inflammation. The analgesic activity of fendosal is considered to be superior to that of aspirin, with the advantage of a prolonged duration of action. The gastric-irritating properties of fendosal are very low in comparison with those of aspirin. Fendosal has a much wider separation of effective and gastric-irritating doses than does aspirin.
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001169:Arthritis, Experimental / Q000503:physiopathology; D004487:Edema / Q000503:physiopathology; D005260:Female; D006099:Granuloma / Q000503:physiopathology; D062385:Hydroxybenzoates; D007211:Indoles; D051381:Rats; D012459:Salicylates
D000894:Anti-Inflammatory Agents, Non-Steroidal; D062385:Hydroxybenzoates; D007211:Indoles; D012459:Salicylates; C016448:fendosal